Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBTC Study 23: Rifabutin for HIV-Related TB
NCT00023361Phase 2Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Feb 1999
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of rifabutin in Tuberculosis (TB), sponsored by Centers for Disease Control and Prevention. Primary endpoint: Rate of confirmed treatment failure and relapse. Started Feb 1999; status: completed.
02
Drugs
rifabutin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00023361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023361.